Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

IOVA holding history

Iovance Biotherapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IOVA overviewAll 13F holders of IOVAFull Q2 2026 holdings

Shares (Q2 2026)
2,143,134
Value
$8.92M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of IOVA by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,143,134$8.92M<0.1%−5,873,219−73.3%ReducedHolders
Q1 20268,016,353$28.1M<0.1%+4,186,558+109.3%AddedHolders
Q4 20253,829,795$10.5M<0.1%+3,753,586+4,925.4%AddedHolders
Q3 202576,209$165.4K<0.1%+20,738+37.4%AddedHolders
Q2 202555,471$95.4K<0.1%+16,195+41.2%AddedHolders
Q1 202539,276$130.8K<0.1%+8,464+27.5%AddedHolders
Q4 202430,812$228.0K<0.1%−36,936−54.5%ReducedHolders
Q3 202467,748$636.2K<0.1%−588,082−89.7%ReducedHolders
Q2 2024655,830$5.26M<0.1%−1,696,336−72.1%ReducedHolders
Q1 20242,352,166$34.9M<0.1%+2,137,032+993.3%AddedHolders
Q4 2023215,134$1.75M<0.1%+177,372+469.7%AddedHolders
Q3 202337,762$171.8K<0.1%−820,994−95.6%ReducedHolders
Q2 2023858,756$6.05M<0.1%−1,501,195−63.6%ReducedHolders
Q1 20232,359,951$14.4M<0.1%−1,861,809−44.1%ReducedHolders
Q4 20224,221,760$27.0M<0.1%+1,526,540+56.6%AddedHolders
Q3 20222,695,220$25.8M<0.1%+617,689+29.7%AddedHolders
Q2 20222,077,531$22.9M<0.1%+1,952,904+1,567.0%AddedHolders
Q1 2022124,627$2.08M<0.1%+52,590+73.0%AddedHolders
Q4 202172,037$1.38M<0.1%+62,523+657.2%AddedHolders
Q3 20219,514$235.0K<0.1%−16,072−62.8%ReducedHolders
Q2 202125,586$666.0K<0.1%−212,183−89.2%ReducedHolders
Q1 2021237,769$7.53M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.